Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine: Perinatal susceptibility, regional variation, and correlation with DNA adducts

Cancer Research

Volumn 61, Issue 24, 2001, Pages 8689-8696

  Steffensen, Inger Lise ^a   Paulsen, Jan Erik ^a   Andreassen, Éshild ^a   Alexander, Jan ^a   Schut, Herman A J ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; DNA; MUTAGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; FEMALE; FOOD COMPOSITION; INTESTINE CANCER; MALE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CARCINOGENS; DISEASE MODELS, ANIMAL; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMIDAZOLES; INJECTIONS, SUBCUTANEOUS; INTESTINAL NEOPLASMS; INTESTINES; MALE; MICE; MICE, INBRED C57BL;

EID: 0035893757     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Diet, nutrition, and avoidable cancer
2. Meat, cooking methods and colorectal cancer: A case-referent study in Stockholm
3. Food-derived mutagens and carcinogens
4. The isolation and identification of a new mutagen from fried ground beef: 2-Amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP)
5. Genotoxicity of compounds from cooked beef in repair-deficient CHO cells versus Salmonella mutagenicity
6. Genotoxicity of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP): Formation of 2-hydroxyamino-PhIP, a directly acting genotoxic metabolite
7. Metabolic fate of heterocyclic amines from cooked food
8. Carcinogenic aromatic amines and amides
9. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines
10. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes
11. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes
12. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in rat extrahepatic tissues
13. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon
14. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s)
15. DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis
16. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP)
17. Induction of intestinal adenocarcinomas by 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in Nagase analbuminemic rats
18. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) carcinogenicity in rats
19. The prostate: A target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) derived from cooked foods
20. Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine
21. 1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine
22. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods
23. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse
24. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
25. Identification and characterization of the familial adenomatous polyposis coli gene
26. Identification of FAP locus genes from chromosome 5q21
27. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
28. Familial polyposis: Recent advances
29. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene
30. Inactivation of both APC alleles in human and mouse tumors
31. Loss of Apc+ in intestinal adenomas from Min mice
32. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis
33. 2-Amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice
34. Δ716 knockout mice
35. Short-term carcinogenicity testing of a potent murine intestinal mutagen, 2-amino-1-metbyl-6-phenylimidazo(4, 5-b)pyridine (PhIP), in Apc1638N transgenic mice
36. Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice
37. + allele
38. Identification and quantification of aberrant crypt foci in the colon of Min mice- a murine model of familial adenomatous polyposis
39. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon
40. Formation of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in male Fischer-344 rats
41. Removal of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in the male Fischer-344 rat
42. 32P-Postlabeling analysis of IQ, MelQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MelQx- and PhIP-treated monkeys
43. Dietary omega-3 fatty acids as potential inhibitors of carcinogenesis: Effect on DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in mice and rats
44. N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: Age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts
45. Carcinogen-specific induction of genetic instability
46. Transfer of the food mutagen PhIP to foetuses and newborn mice following maternal exposure
47. DNA adduct formation, cell proliferation and aberrant crypt focus formation induced by PhIP in male and female rat colon with relevance to carcinogenesis
48. Perinatal period and pregnancy: Intervals of high risk for chemical carcinogens
49. Perinatal toxicology: Its recognition and fundamentals
50. How are children different from adults?
51. Critical windows of exposure for children’s health: Cancer in human epidemiological studies and neoplasms in experimental animal models
52. Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in DNA repair deficient XPA-/- mice
53. Susceptibility of C57BL/6 mice to tumorigenicity induced by dimethylnitrosamine and 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in the neonatal bioassay
54. DNA adducts, mutations and cancer
55. A new approach to risk estimation of food-borne carcinogens - Heterocyclic amines - Based on molecular information
56. Min mouse adenomas and uninvolved mucosa
57. DNA adduct levels and intestinal lesions in congenic rapid and slow acetylator Syrian hamsters administered the food mutagens 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4, 5-f]quinoline (IQ)
58. 2-Amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine is a potent mutagen in the mouse small intestine
59. Colon-specific genotoxicity of heterocyclic amines detected by the modified alkaline single cell gel electrophoresis assay of multiple mouse organs
60. Effects of human and rat glutathione 5-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: A possible mechanism of organ specificity in their carcinogenesis
61. Longitudinal distribution of arylamine N-acetyl-transferases in the intestine of the hamster, mouse, and rat
62. The Min (multiple intestinal neoplasia) mutation: Its effect on gut epithelial cell differentiation and interaction with a modifier system
63. A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel
64. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2
65. Mucosa-specific, DNA adducts in human small intestine: A comparison with the colon